MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$1,951M
Free Cash flow
$3,489M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Accrued sales incentives and all...
Depreciation, amortization and o...
Accrued liabilities
Others
Negative Cash Flow Breakdown
Manufacturing cost of sales
Research and development
Dividends paid
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
-
-
36,751
-
Manufacturing cost of sales
-
-
9,845
-
Profit share and royalties in cost of sales
-
-
2,192
-
Research and development
-
-
7,272
-
Sales and marketing
-
-
4,590
-
General and administrative
-
-
2,460
-
Other segment items
-
-
-931
-
Interest income
-
-
408
-
Interest expense, net
-
-
2,755
-
Total revenues
10,054
-18,267
-
9,557
Manufacturing cost of sales
2,139
-5,340
-
2,508
Profit share and royalties in cost of sales
672
-977
-
574
Research and development
1,868
-3,411
-
1,900
Sales and marketing
1,155
-2,166
-
1,097
General and administrative
590
-1,330
-
623
Other segment items
314
1,589
-
-1,642
Equity in (income) loss of equity method investments
-
-
-
10
Interest income
125
-210
-
99
Interest expense, net
673
-1,445
-
685
Provision for income taxes
393
265
181
705
Net income
2,375
1,819
1,333
3,216
Depreciation, amortization and other
1,112
1,116
1,132
1,307
Impairment of intangible assets
0
0
0
400
Stock-based compensation expense
165
75
125
127
Deferred income taxes
-291
-176
-19
-30
Loss (gain) on equity securities
-158
-143
-648
1,971
Other items, net
-75
67
-250
28
Trade receivables, net
1,093
-413
1,075
-222
Inventories
31
-18
-119
-240
Other assets
330
-8
577
283
Accounts payable
-70
571
-484
-174
Accrued income taxes, net
-131
71
-365
610
Long-term tax liabilities
77
71
75
74
Accrued liabilities
901
-959
749
-200
Accrued sales incentives and allowance
1,117
-839
-232
1,184
Other liabilities
-32
-75
-76
-10
Net cash provided by operating activities
4,002
2,189
1,603
4,684
Cash paid for acquisitions, net of cash acquired
-
-
53
-
Proceeds from sales of marketable securities
-
-
0
-
Proceeds from maturities of marketable securities
-
-
0
-
Purchases of property, plant and equipment
513
712
642
436
Other
56
4
-2
-22
Net cash used in investing activities
-569
-716
-693
-414
Net proceeds from issuance of debt
0
3,964
0
-
Extinguishment of debt
0
233
0
81
Repayment of debt
0
833
0
1,500
Repurchases of common stock
-
-
0
-
Dividends paid
1,362
1,358
1,283
1,282
Other
-120
-104
57
10
Net cash used in financing activities
-1,482
1,436
-1,226
-2,853
Increase (decrease) in cash and cash equivalents
1,951
2,909
-316
1,417
Cash and cash equivalents at beginning of period
12,038
9,129
8,810
8,810
Cash and cash equivalents at end of period
13,989
12,038
9,129
9,445
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
AMGN Cash Flow Sankey Diagram
Sankey diagram visualizing AMGN cash flow for the period
Total revenues
$10,054M
(9.53%↑ Y/Y)
Interest income
$125M
(45.35%↑ Y/Y)
Net income
$2,375M
(65.85%↑ Y/Y)
Accrued sales
incentives and allowance
$1,117M
(78.15%↑ Y/Y)
Depreciation, amortization
and other
$1,112M
(-17.08%↓ Y/Y)
Canceled cashflow
$7,804M
Accrued liabilities
$901M
(9.34%↑ Y/Y)
Stock-based compensation
expense
$165M
(5.10%↑ Y/Y)
Loss (gain) on equity
securities
-$158M
(71.48%↑ Y/Y)
Long-term tax liabilities
$77M
(-16.30%↓ Y/Y)
Other items, net
-$75M
(-426.09%↓ Y/Y)
Net cash provided by
operating activities
$4,002M
(75.53%↑ Y/Y)
Canceled cashflow
$1,978M
Manufacturing cost of sales
$2,139M
(-13.89%↓ Y/Y)
Research and development
$1,868M
(7.11%↑ Y/Y)
Sales and marketing
$1,155M
(1.58%↑ Y/Y)
Interest expense, net
$673M
(-3.03%↓ Y/Y)
Profit share and
royalties in cost of sales
$672M
(27.51%↑ Y/Y)
General and
administrative
$590M
(6.50%↑ Y/Y)
Provision for income taxes
$393M
(188.97%↑ Y/Y)
Other segment items
$314M
(-41.74%↓ Y/Y)
Increase (decrease) in
cash and cash...
$1,951M
(349.49%↑ Y/Y)
Canceled cashflow
$2,051M
Trade receivables,
net
$1,093M
(112.23%↑ Y/Y)
Other assets
$330M
(60.19%↑ Y/Y)
Deferred income taxes
-$291M
(31.04%↑ Y/Y)
Accrued income taxes,
net
-$131M
(94.58%↑ Y/Y)
Accounts payable
-$70M
(-111.88%↓ Y/Y)
Other liabilities
-$32M
(-500.00%↓ Y/Y)
Inventories
$31M
(112.97%↑ Y/Y)
Net cash used in
financing activities
-$1,482M
(44.56%↑ Y/Y)
Net cash used in
investing activities
-$569M
(-46.27%↓ Y/Y)
Dividends paid
$1,362M
(6.41%↑ Y/Y)
Other
-$120M
(-30.43%↓ Y/Y)
Purchases of property,
plant and equipment
$513M
(39.02%↑ Y/Y)
Other
$56M
(180.00%↑ Y/Y)
Buy us a coffee
amgen-blue-svg
AMGEN INC (AMGN)
amgen-blue-svg
AMGEN INC (AMGN)